Elevance Health (ELV) FY2021 results: revenue $138.6 billion, up 13.8% on the year
Elevance Health, Inc. (ELV) reported revenue of $138.6 billion for fiscal 2021, the year ended 31 December 2021, up 13.8% on the year before. Net income was $6.2 billion, up 34.7%, and diluted earnings per share $24.95. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2022.
Revenue
$138.6 billion
+13.8% on the year
FY2014FY2021
Operating margin
5.5%
5.2% a year earlier
FY2014FY2021
Net income
$6.2 billion
+34.7% on the year
FY2014FY2021
Diluted EPS
$24.95
+38.8% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
8,364
10,688
6,061
-21.7%
Capital expenditure
1,087
1,021
1,077
+6.5%
Free cash flow
7,277
9,667
4,984
-24.7%
Free cash flow margin
5.2%
7.9%
4.8%
Cash from investing
-9,638
-7,324
-2,792
Cash from financing
423
-2,567
-2,266
Depreciation and amortisation
1,302
1,154
1,133
+12.8%
Share-based compensation
255
283
294
-9.9%
Buybacks
1,900
2,700
1,701
-29.6%
Dividends paid
1,104
954
818
+15.7%
Dividend per share
$4.52
$3.80
$3.20
+18.9%
Diluted shares, weighted
247m
254m
260m
-2.9%
Shares outstanding at period end
242m
245m
253m
-1.5%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
36,060
33,199
31,728
+8.6%
Non-controlling interest
68.0
0.0
n/a
Short-term borrowings
n/a
0.0
n/a
Debt
23,031
20,035
20,085
+15.0%
Operating lease liabilities
864
n/a
n/a
Other liabilities
37,437
33,381
25,640
+12.2%
Total liabilities and equity
97,460
86,615
77,453
+12.5%
Fixed assets
3,919
3,483
3,133
+12.5%
Goodwill
24,228
21,691
20,500
+11.7%
Intangible assets
10,615
9,405
8,674
+12.9%
Investments
26,899
23,995
20,181
+12.1%
Cash and equivalents
4,880
5,741
4,937
-15.0%
Other assets
26,919
22,300
20,028
+20.7%
Total assets
97,460
86,615
77,453
+12.5%
10-K for the year ended 31 December 2021, filed 16 February 2022: the filing.